Tran, Tina
Senger, Stefania
Baldassarre, Mariella
Brosnan, Rachel A.
Cristofori, Fernanda
Crocco, Marco
De Santis, Stefania
Elli, Luca
Faherty, Christina S.
Francavilla, Ruggero
Goodchild-Michelman, Isabella
Kenyon, Victoria A.
Leonard, Maureen M.
Lima, Rosiane S.
Malerba, Federica
Montuori, Monica
Morelli, Annalisa
Norsa, Lorenzo
Passaro, Tiziana
Piemontese, Pasqua
Reed, James C.
Sansotta, Naire
Valitutti, Francesco
Zomorrodi, Ali R.
Fasano, Alessio
Forchielli, Maria Luisa
Serretiello, Adelaide
Vecchi, Corrado
de Villasante, Gemma Castillejo
Venutolo, Giorgia
Malamisura, Basilio
Calvi, Angela
Lionetti, Maria Elena
Baldassarre, Mariella
Trovato, Chiara Maria
Pietropaoli, Nicoletta
Perrone, Michela
Raguseo, Lidia Celeste
Catassi, Carlo
,
Article History
Received: 16 August 2023
Revised: 9 November 2023
Accepted: 18 November 2023
First Online: 4 January 2024
Competing interests
: V.A.K. serves as a consultant for Takeda Pharmaceuticals. M.M.L. acted as a consultant for Anokion. A.F. is a stockholder at Alba Therapeutics, serves as a consultant for 9Meters, is an advisory board member for Axial Biotherapeutics, and has a speaker agreement with Mead Johnson Nutrition and Sanofi. Other authors have declared that no conflict of interest exists. None of the above financial disclosures are related to this work.
: Informed Consent was obtained, and the study was approved by the Massachusetts General Brigham Institutional Review Board.